8月11日，Hims & Hers Health盘前下跌6.37%，报29.57美元/股。消息面上，公司发布第二季度财报，每股亏损0.37美元，远超市场预期的0.03-0.05美元亏损，较去年同期每股盈利0.17美元大幅恶化，由盈转亏。
财报显示，公司Q2营收7.53亿美元，同比增长38%，订阅用户增至约289万，全年营收指引上调至31亿至33亿美元，均超市场预期。但毛利率从去年同期的76%骤降至64%，管理层表示国际业务拓展及品牌GLP-1减肥药销售拖累利润率并产生重组成本。CFO预计毛利率将长期维持在历史低位以下。尽管营收表现亮眼且管理层对2030年至少65亿美元营收目标信心增强，但巨额亏损仍令投资者信心承压。
Hims & Hers Health Inc是一家多专业远程医疗平台，将消费者与持牌医疗保健专业人员联系起来，使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.